Tumor necrosis factor-alpha promoter polymorphisms are associated with idiopathic primary ovarian insufficiency in Korean women

Fertil Steril. 2012 Nov;98(5):1260-5.e1-2. doi: 10.1016/j.fertnstert.2012.07.1111. Epub 2012 Aug 9.

Abstract

Objective: To investigate the possible association between primary ovarian insufficiency (POI) and TNF-α gene polymorphisms in Korean women.

Design: Case-control study.

Setting: An urban university-based hospital in South Korea.

Patient(s): A cohort of 135 Korean POI patients and 236 controls.

Intervention(s): None.

Main outcome measure(s): We analyzed TNF-α gene variants of all participants using the polymerase chain reaction-restriction fragment length polymorphism assay.

Result(s): The TNF-α -1031TC+CC, -238GA+AA, -1031TC+CC/-308GG, -1031TT/-308GA+AA, -1031TC+CC/-238GA+AA, and -308GG/-238GA+AA genotypes were significantly more frequent in POI patients than in controls. Among the haplotypes for the three TNF-α loci, the -1031C/-308G/-238A haplotype was more frequent in POI patients than in controls and conferred POI susceptibility. In analyses of two loci, the -1031T/-308A, -1031C/-308G, -1031C/-238A, and -308G/-238A haplotypes were more frequent in POI patients.

Conclusion(s): The TNF-α -1031C and -238A alleles had strong association with POI. The TNF-α -308A allele showed limited significance for POI risk with the presence of the -1031T allele. Our data suggest that the minor alleles of TNF-α promoter polymorphisms may increase POI risk in Korean women.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Adult
  • Asian People / genetics*
  • Biomarkers / blood
  • Case-Control Studies
  • Estradiol / blood
  • Female
  • Fertility / genetics*
  • Fertility / immunology
  • Follicle Stimulating Hormone, Human / blood
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Luteinizing Hormone / blood
  • Odds Ratio
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Primary Ovarian Insufficiency / blood
  • Primary Ovarian Insufficiency / ethnology
  • Primary Ovarian Insufficiency / genetics*
  • Primary Ovarian Insufficiency / immunology
  • Primary Ovarian Insufficiency / physiopathology
  • Promoter Regions, Genetic*
  • Republic of Korea / epidemiology
  • Risk Assessment
  • Risk Factors
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Biomarkers
  • Follicle Stimulating Hormone, Human
  • Tumor Necrosis Factor-alpha
  • Estradiol
  • Luteinizing Hormone